TrialBMC pulmonary medicine2019

Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma.

Mattis Gottlow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.